top of page
News, Events and Updates
Search
Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer
Jan 2, 2019
Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update
Dec 12, 2018
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, 12/12/2018
Dec 10, 2018
Anavex Life Sciences Strengthens its Scientific Advisory Board with Distinguished Researcher for Cli
Nov 8, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73
Oct 29, 2018
Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX®2-73
Oct 25, 2018
Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial ANAVEX®2-73 for Rett Syndrome
Oct 18, 2018
Anavex Life Sciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Sep 25, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73
Aug 28, 2018
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results
Aug 8, 2018
Anavex Life Sciences to Announce Fiscal Third Quarter 2018 Financial Results on Thursday, 8/9/2018
Aug 6, 2018
20
21
22
23
24
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
